Patent & IP news for May 8, 2017

Never Too Late: If you missed the IPKat last week! from ipkitten.blogspot.com

Been away and want to catch up on last week's IP news? No problem! As always, the IPKat is here to bring you a quick summary -- the 145th edition of Never Too Late.
Should ...

Share via E–mail | Twitter | Facebook

PTAB Life Sciences Report from www.patentdocs.org

By John Cravero -- About the PTAB Life Sciences Report: Each month we will report on developments at the PTAB involving life sciences patents. Pain Point Medical Systems, Inc. v. Blephex LLC PTAB Petition: IPR2016-01670; filed ...

Share via E–mail | Twitter | Facebook

Adding defendants in Glaxo v Sandoz from ipkitten.blogspot.com

Glaxo's registered trade markCan you add defendants to a claim when their involvement was at the design stage of a product several years before the product was launched (and outside the limitation period)?

The ...

Share via E–mail | Twitter | Facebook

10th Intl Legal Alliance Summit in NY, June 15, will confer IP awards from ipcloseup.com

The International Legal Alliance Summit & Awards will celebrate its tenth anniversary in New York on June 15, 2017 with approximately 500 in-house counsel and law firms from around the world. Attendees will discuss such hot ...

Share via E–mail | Twitter | Facebook

The True Believer: An Interview With New IFPMA Director General Thomas Cueni from www.ip-watch.org

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change ...

Share via E–mail | Twitter | Facebook

Patent for Efficiently Monitoring and Transmitting Patient Data Not Invalid Under 35 U.S.C. § 101 from docketreport.blogspot.com

The court denied defendant's motion for judgment on the pleadings that plaintiffs’ patent for efficiently monitoring and transmitting patient data encompassed unpatentable subject matter because the asserted claims did not lack an inventive concept ...

Share via E–mail | Twitter | Facebook

Off-Book Claim Constructions: PTAB Free to Follow its Own Path from patentlyo.com

Intellectual Ventures v. Ericsson (Fed. Cir. 2017) In a non-precedential decision, the Federal Circuit has rejected IV’s procedural due process claim against the PTAB – holding that the PTAB is free to construe claims in ...

Share via E–mail | Twitter | Facebook

Intellectual Ventures loses appeal at CAFC of IPR decisions: 2016-1739, 2016-1740, 2016-1741 from ipbiz.blogspot.com




Following institution of inter partes reviews, the
United States Patent Trial and Appeal Board found
certain claims of Intellectual Ventures’ patents anticipated
by or obvious over the prior art. Intellectual Ventures
appeals from those decisions ...

Share via E–mail | Twitter | Facebook

Multinational Subsidiaries - The Four Bridges from intellectualprofit.blogspot.com

When you are running a multinational subsidiary, you start it, staff it and scale it. Day-to-day activities occupy the bulk of your attention. It is absolutely correct that you should concentrate on this – it is ...

Share via E–mail | Twitter | Facebook

Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc. (Fed. Cir. 2017) from www.patentdocs.org

By Kevin E. Noonan -- The Federal Circuit's decision on Friday, in Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc., illustrates the risks a litigant can take when agreeing to stipulation in an effort at least ...

Share via E–mail | Twitter | Facebook